Literature DB >> 25600866

Cooperation between Noncanonical Ras Network Mutations.

Edward C Stites1, Paul C Trampont2, Lisa B Haney3, Scott F Walk3, Kodi S Ravichandran4.   

Abstract

Cancer develops after the acquisition of a collection of mutations that together create the cancer phenotype. How collections of mutations work together within a cell and whether there is selection for certain combinations of mutations are not well understood. We investigated this problem with a mathematical model of the Ras signaling network, including a computational random mutagenesis. Modeling and subsequent experiments revealed that mutations of the tumor suppressor gene NF1 can amplify the effects of other Ras pathway mutations, including weakly activating, noncanonical Ras mutants. Furthermore, analyzing recently available, large, cancer genomic data sets uncovered increased co-occurrence of NF1 mutations with mutations in other Ras network genes. Overall, these data suggest that combinations of Ras pathway mutations could serve the role of cancer "driver." More generally, this work suggests that mutations that result in network instability may promote cancer in a manner analogous to genomic instability.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2015        PMID: 25600866      PMCID: PMC4503519          DOI: 10.1016/j.celrep.2014.12.035

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  29 in total

Review 1.  GTPase activating proteins: critical regulators of intracellular signaling.

Authors:  Shane Donovan; Kevin M Shannon; Gideon Bollag
Journal:  Biochim Biophys Acta       Date:  2002-03-14

Review 2.  Mathematical investigation of how oncogenic ras mutants promote ras signaling.

Authors:  Edward C Stites; Kodi S Ravichandran
Journal:  Methods Mol Biol       Date:  2012

3.  BRAF mutations in hairy-cell leukemia.

Authors:  Enrico Tiacci; Vladimir Trifonov; Gianluca Schiavoni; Antony Holmes; Wolfgang Kern; Maria Paola Martelli; Alessandra Pucciarini; Barbara Bigerna; Roberta Pacini; Victoria A Wells; Paolo Sportoletti; Valentina Pettirossi; Roberta Mannucci; Oliver Elliott; Arcangelo Liso; Achille Ambrosetti; Alessandro Pulsoni; Francesco Forconi; Livio Trentin; Gianpietro Semenzato; Giorgio Inghirami; Monia Capponi; Francesco Di Raimondo; Caterina Patti; Luca Arcaini; Pellegrino Musto; Stefano Pileri; Claudia Haferlach; Susanne Schnittger; Giovanni Pizzolo; Robin Foà; Laurent Farinelli; Torsten Haferlach; Laura Pasqualucci; Raul Rabadan; Brunangelo Falini
Journal:  N Engl J Med       Date:  2011-06-11       Impact factor: 91.245

4.  A negative feedback signaling network underlies oncogene-induced senescence.

Authors:  Stéphanie Courtois-Cox; Sybil M Genther Williams; Elizabeth E Reczek; Bryan W Johnson; Lauren T McGillicuddy; Cory M Johannessen; Pablo E Hollstein; Mia MacCollin; Karen Cichowski
Journal:  Cancer Cell       Date:  2006-12       Impact factor: 31.743

5.  The tumor suppressor neurofibromin confers sensitivity to apoptosis by Ras-dependent and Ras-independent pathways.

Authors:  S Shapira; B Barkan; E Friedman; E Fridman; Y Kloog; R Stein
Journal:  Cell Death Differ       Date:  2006-11-10       Impact factor: 15.828

6.  A genome-scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition.

Authors:  Steven R Whittaker; Jean-Philippe Theurillat; Eliezer Van Allen; Nikhil Wagle; Jessica Hsiao; Glenn S Cowley; Dirk Schadendorf; David E Root; Levi A Garraway
Journal:  Cancer Discov       Date:  2013-01-03       Impact factor: 39.397

7.  Network analysis of oncogenic Ras activation in cancer.

Authors:  Edward C Stites; Paul C Trampont; Zhong Ma; Kodi S Ravichandran
Journal:  Science       Date:  2007-10-19       Impact factor: 47.728

Review 8.  The cancer genome.

Authors:  Michael R Stratton; Peter J Campbell; P Andrew Futreal
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

9.  COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.

Authors:  Cory M Johannessen; Jesse S Boehm; So Young Kim; Sapana R Thomas; Leslie Wardwell; Laura A Johnson; Caroline M Emery; Nicolas Stransky; Alexandria P Cogdill; Jordi Barretina; Giordano Caponigro; Haley Hieronymus; Ryan R Murray; Kourosh Salehi-Ashtiani; David E Hill; Marc Vidal; Jean J Zhao; Xiaoping Yang; Ozan Alkan; Sungjoon Kim; Jennifer L Harris; Christopher J Wilson; Vic E Myer; Peter M Finan; David E Root; Thomas M Roberts; Todd Golub; Keith T Flaherty; Reinhard Dummer; Barbara L Weber; William R Sellers; Robert Schlegel; Jennifer A Wargo; William C Hahn; Levi A Garraway
Journal:  Nature       Date:  2010-11-24       Impact factor: 49.962

10.  Exploring the contextual sensitivity of factors that determine cell-to-cell variability in receptor-mediated apoptosis.

Authors:  Suzanne Gaudet; Sabrina L Spencer; William W Chen; Peter K Sorger
Journal:  PLoS Comput Biol       Date:  2012-04-26       Impact factor: 4.475

View more
  15 in total

1.  Tumorigenesis: Mutant relationships.

Authors:  Sarah Seton-Rogers
Journal:  Nat Rev Cancer       Date:  2015-02-12       Impact factor: 60.716

Review 2.  New insights into RAS biology reinvigorate interest in mathematical modeling of RAS signaling.

Authors:  Keesha E Erickson; Oleksii S Rukhlenko; Richard G Posner; William S Hlavacek; Boris N Kholodenko
Journal:  Semin Cancer Biol       Date:  2018-03-05       Impact factor: 15.707

Review 3.  RASopathy Gene Mutations in Melanoma.

Authors:  Ruth Halaban; Michael Krauthammer
Journal:  J Invest Dermatol       Date:  2016-05-25       Impact factor: 8.551

4.  RasGRP1 overexpression in T-ALL increases basal nucleotide exchange on Ras rendering the Ras/PI3K/Akt pathway responsive to protumorigenic cytokines.

Authors:  O Ksionda; A A Melton; J Bache; M Tenhagen; J Bakker; R Harvey; S S Winter; I Rubio; J P Roose
Journal:  Oncogene       Date:  2015-11-09       Impact factor: 9.867

5.  A prognostic predictive model constituted with gene mutations of APC, BRCA2, CDH1, SMO, and TSC2 in colorectal cancer.

Authors:  Lei Zheng; Yang Zhan; Jia Lu; Jun Hu; Dalu Kong
Journal:  Ann Transl Med       Date:  2021-04

6.  Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis.

Authors:  Soojin Cha; Jeongeun Lee; Jong-Yeon Shin; Ji-Yeon Kim; Sung Hoon Sim; Bhumsuk Keam; Tae Min Kim; Dong-Wan Kim; Dae Seog Heo; Se-Hoon Lee; Jong-Il Kim
Journal:  BMC Cancer       Date:  2016-02-29       Impact factor: 4.430

Review 7.  Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance.

Authors:  Markus Morkel; Pamela Riemer; Hendrik Bläker; Christine Sers
Journal:  Oncotarget       Date:  2015-08-28

8.  Linking FOXO3, NCOA3, and TCF7L2 to Ras pathway phenotypes through a genome-wide forward genetic screen in human colorectal cancer cells.

Authors:  Snehangshu Kundu; Muhammad Akhtar Ali; Niklas Handin; Narendra Padhan; Jimmy Larsson; Maria Karoutsou; Kenneth Ban; Jacek R Wiśniewski; Per Artursson; Liqun He; Mats Hellström; Tobias Sjöblom
Journal:  Genome Med       Date:  2018-01-04       Impact factor: 11.117

9.  Evidence of Cooperation between Hippo Pathway and RAS Mutation in Thyroid Carcinomas.

Authors:  Thaise Nayane Ribeiro Carneiro; Larissa Valdemarin Bim; Vanessa Candiotti Buzatto; Vanessa Galdeno; Paula Fontes Asprino; Eunjung Alice Lee; Pedro Alexandre Favoretto Galante; Janete Maria Cerutti
Journal:  Cancers (Basel)       Date:  2021-05-12       Impact factor: 6.639

10.  Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas.

Authors:  Michael Krauthammer; Yong Kong; Antonella Bacchiocchi; Perry Evans; Natapol Pornputtapong; Cen Wu; Jamie P. McCusker; Shuangge Ma; Elaine Cheng; Robert Straub; Merdan Serin; Marcus Bosenberg; Stephan Ariyan; Deepak Narayan; Mario Sznol; Harriet M Kluger; Shrikant Mane; Joseph Schlessinger; Richard P Lifton; Ruth Halaban
Journal:  Nat Genet       Date:  2015-07-27       Impact factor: 41.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.